评估转移性结直肠癌姑息化疗的最新进展。
Evaluating the recent developments in palliative chemotherapy for metastatic colorectal cancer.
机构信息
Department of Internal Medicine, Kyung Hee University Hospital, Seoul, Korea.
Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Korea.
出版信息
Korean J Intern Med. 2019 Nov;34(6):1188-1196. doi: 10.3904/kjim.2019.071. Epub 2019 Jul 29.
Abstract
The incidence of colorectal cancer (CRC) has increased. CRC is the third most common cancer and the fourth most common cause of cancer-related deaths in Korea. Palliative chemotherapy can be used to shrink tumors and ease symptoms caused by the cancer when cure is not possible. It is important to identify chemotherapeutic agents that can be used to effectively treat metastatic CRC (mCRC) and thus improve the survival and quality of life of patients with mCRC. This review aimed to evaluate the recent developments in palliative chemotherapy for mCRC and the biological or targeted agents used based on genetic alterations.
摘要
结直肠癌（CRC）的发病率正在上升。CRC 是韩国第三大常见癌症和第四大癌症相关死亡原因。当无法治愈时，姑息性化疗可用于缩小肿瘤并缓解癌症引起的症状。确定可有效治疗转移性 CRC（mCRC）的化疗药物，从而改善 mCRC 患者的生存和生活质量非常重要。本综述旨在评估 mCRC 姑息化疗的最新进展以及基于遗传改变使用的生物或靶向药物。
相似文献
1
Evaluating the recent developments in palliative chemotherapy for metastatic colorectal cancer.评估转移性结直肠癌姑息化疗的最新进展。
Korean J Intern Med. 2019 Nov;34(6):1188-1196. doi: 10.3904/kjim.2019.071. Epub 2019 Jul 29.
2
Personalizing medicine for metastatic colorectal cancer: current developments.转移性结直肠癌的个性化医疗：当前进展
World J Gastroenterol. 2014 Aug 14;20(30):10425-31. doi: 10.3748/wjg.v20.i30.10425.
3
Current and future targets and therapies in metastatic colorectal cancer.转移性结直肠癌的当前及未来靶点与治疗方法
J BUON. 2019 Sep-Oct;24(5):1785-1792.
4
Systemic Therapy for Metastatic Colorectal Cancer: From Current Standards to Future Molecular Targeted Approaches.转移性结直肠癌的全身治疗：从当前标准到未来分子靶向方法
Am Soc Clin Oncol Educ Book. 2017;37:246-256. doi: 10.1200/EDBK_175679.
5
MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.微小 RNA 与结直肠癌的预后和治疗：从基础到临床。
World J Gastroenterol. 2018 Jul 21;24(27):2949-2973. doi: 10.3748/wjg.v24.i27.2949.
6
Rationally designed treatment for metastatic colorectal cancer: current drug development strategies.转移性结直肠癌的合理设计治疗：当前药物开发策略
World J Gastroenterol. 2014 Aug 14;20(30):10288-95. doi: 10.3748/wjg.v20.i30.10288.
7
The evolution of biomarkers to guide the treatment of metastatic colorectal cancer.生物标志物的演进指导转移性结直肠癌的治疗。
Am J Manag Care. 2018 Apr;24(7 Suppl):S107-S117.
8
Current and evolving biomarkers for precision oncology in the management of metastatic colorectal cancer.转移性结直肠癌管理中精准肿瘤学的当前及不断发展的生物标志物
Chin Clin Oncol. 2019 Oct;8(5):49. doi: 10.21037/cco.2019.08.08. Epub 2019 Sep 3.
9
Predictive and prognostic markers in the treatment of metastatic colorectal cancer (mCRC): personalized medicine at work.转移性结直肠癌（mCRC）治疗中的预测性和预后性标志物：个性化医疗的应用
Hematol Oncol Clin North Am. 2015 Feb;29(1):43-60. doi: 10.1016/j.hoc.2014.09.009.
10
Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients.为何精准医学应应用于转移性结直肠癌患者的全程照护。
Future Oncol. 2020 Jan;16(2):4337-4339. doi: 10.2217/fon-2019-0624. Epub 2019 Dec 3.
引用本文的文献
1
Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis.免疫疗法在结直肠癌肝转移治疗中的新作用
Onco Targets Ther. 2020 Nov 13;13:11645-11658. doi: 10.2147/OTT.S271955. eCollection 2020.
本文引用的文献
1
HER2: An emerging target in colorectal cancer.人表皮生长因子受体2：结直肠癌中的一个新兴靶点。
Curr Probl Cancer. 2018 Nov;42(6):560-571. doi: 10.1016/j.currproblcancer.2018.07.001. Epub 2018 Jul 19.
2
Recent Advances in the Clinical Development of Immune Checkpoint Blockade Therapy for Mismatch Repair Proficient (pMMR)/non-MSI-H Metastatic Colorectal Cancer.免疫检查点阻断疗法在错配修复 proficient（pMMR）/非微卫星高度不稳定转移性结直肠癌临床开发方面的最新进展
Clin Colorectal Cancer. 2018 Dec;17(4):258-273. doi: 10.1016/j.clcc.2018.06.004. Epub 2018 Jun 21.
3
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer.纳武利尤单抗联合伊匹单抗治疗错配修复缺陷/微卫星高度不稳定转移性结直肠癌的持久临床获益。
J Clin Oncol. 2018 Mar 10;36(8):773-779. doi: 10.1200/JCO.2017.76.9901. Epub 2018 Jan 20.
4
BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives.BRAF 突变型结直肠癌：预后、治疗和新视角。
Ann Oncol. 2017 Nov 1;28(11):2648-2657. doi: 10.1093/annonc/mdx401.
5
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.一线化疗联合西妥昔单抗或贝伐单抗对KRAS野生型晚期或转移性结直肠癌患者总生存期的影响：一项随机临床试验
JAMA. 2017 Jun 20;317(23):2392-2401. doi: 10.1001/jama.2017.7105.
6
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials.在六个随机试验中，接受化疗和 EGFR 靶向抗体治疗的 RAS 野生型转移性结直肠癌患者中，原发肿瘤侧的预后和预测价值。
Ann Oncol. 2017 Aug 1;28(8):1713-1729. doi: 10.1093/annonc/mdx175.
7
Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group.S-1 对比卡培他滨用于转移性结直肠癌一线治疗的随机 III 期临床试验：荷兰结直肠癌研究组 SALTO 研究。
Ann Oncol. 2017 Jun 1;28(6):1288-1293. doi: 10.1093/annonc/mdx122.
8
Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses of the CRYSTAL and FIRE-3 Trials.RAS野生型转移性结直肠癌患者中原发肿瘤部位的预后和预测相关性：CRYSTAL和FIRE-3试验的回顾性分析
JAMA Oncol. 2017 Feb 1;3(2):194-201. doi: 10.1001/jamaoncol.2016.3797.
9
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial.FOLFIRI 联合西妥昔单抗对比 FOLFIRI 联合贝伐珠单抗治疗转移性结直肠癌（FIRE-3）：这项随机、开放标签的 3 期临床试验最终 RAS 野生型亚组中肿瘤动态的事后分析。
Lancet Oncol. 2016 Oct;17(10):1426-1434. doi: 10.1016/S1470-2045(16)30269-8. Epub 2016 Aug 27.
10
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.ESMO 共识指南：转移性结直肠癌患者的管理。
Ann Oncol. 2016 Aug;27(8):1386-422. doi: 10.1093/annonc/mdw235. Epub 2016 Jul 5.
Zotero 插件